Woodline Partners’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14M | Sell |
|
|||||
|
2025
Q2 | $21.7M | Sell |
|
|||||
|
2025
Q1 | $14.4M | Sell |
|
|||||
|
2024
Q4 | $21.6M | Buy |
|
|||||
|
2024
Q3 | $24.9M | Buy |
|
|||||
|
2024
Q2 | $15.5M | Buy |
|
|||||
|
2024
Q1 | $20.1M | Buy |
|
|||||
|
2023
Q4 | $2.57M | Sell |
|
|||||
|
2023
Q3 | $1.43M | Sell |
|
|||||
|
2023
Q2 | $2.5M | Buy |
|
|||||
|
2023
Q1 | $2.96M | Buy |
|
|||||
|
2022
Q4 | $2.5M | Hold |
|
|||||
|
2022
Q3 | $2.18M | Hold |
|
|||||
|
2022
Q2 | $1.97M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $7.6M | Buy |
|
|||||
|
2021
Q2 | $1.83M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $10.5M | Buy |
|
|||||
|
2020
Q3 | $5.37M | Buy |
|